Anixa Biosciences is trading 8.31% down in pre-market at $3.20, amid broader risk-off sentiment.
- Closed at $3.49 on August 17, 2026, when it gained 9.75%.
- No new company-specific announcement or clear negative catalyst was identified in available August 18 coverage; the latest investor-relations releases remain earlier clinical, patent, and insider-activity updates.
- Nasdaq futures were down 1.17%, while geopolitical tensions, higher oil prices, and rising Treasury yields pressured equities broadly.